The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
about
Drugs for treating Schistosoma mansoni infectionOne health - an ecological and evolutionary framework for tackling Neglected Zoonotic DiseasesHybridization in Parasites: Consequences for Adaptive Evolution, Pathogenesis, and Public Health in a Changing WorldSignificantly reduced intensity of infection but persistent prevalence of schistosomiasis in a highly endemic region in Mali after repeated treatmentA research agenda for helminth diseases of humans: basic research and enabling technologies to support control and elimination of helminthiasesBayesian risk mapping and model-based estimation of Schistosoma haematobium-Schistosoma mansoni co-distribution in Côte d'IvoireEpidemiological Interactions between Urogenital and Intestinal Human Schistosomiasis in the Context of Praziquantel Treatment across Three West African CountriesIntegrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites.Cytokine responses to Schistosoma mansoni and Schistosoma haematobium in relation to infection in a co-endemic focus in northern Senegal.Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal.The use of imaging to detect schistosomes and diagnose schistosomiasisEstimation of changes in the force of infection for intestinal and urogenital schistosomiasis in countries with schistosomiasis control initiative-assisted programmes.Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysisThe WHO ultrasonography protocol for assessing hepatic morbidity due to Schistosoma mansoni. Acceptance and evolution over 12 years.The WHO ultrasonography protocol for assessing morbidity due to Schistosoma haematobium. Acceptance and evolution over 14 years. Systematic review.Hybridizations within the Genus Schistosoma: implications for evolution, epidemiology and control.Population genetics of Schistosoma haematobium: development of novel microsatellite markers and their application to schistosomiasis control in Mali.Design and optimization of thermosensitive nanoemulsion hydrogel for sustained-release of praziquantel.Opportunities and challenges for modelling epidemiological and evolutionary dynamics in a multihost, multiparasite system: Zoonotic hybrid schistosomiasis in West Africa.Giardia duodenalis assemblage-specific induction of apoptosis and tight junction disruption in human intestinal epithelial cells: effects of mixed infections.Schistosomiasis: Clinical management of liver diseaseHalting - associated bladder cancer
P2860
Q24201000-64FDA0E3-AA4F-4F79-B944-99B1217FECD2Q26770430-E743488E-3964-47E6-8B11-F6F712F20B36Q26786073-884A214E-E5E6-4C52-8090-7155889A321EQ28481702-482AEEB1-B0C9-49BF-A77C-EA88F2CD68A5Q28482492-598E0749-F805-47F5-ABFB-B90F9406B052Q28542763-A81F9CC2-68FE-4E9E-9D4E-D8D7462DFE3BQ28550322-2CE364E3-8E80-45CE-8398-670875FBD113Q33958836-839F3EC4-93EF-4CA6-AB7D-9161860A4A79Q34015496-8760A17A-BE16-4BF8-871D-68A150BB501EQ34431580-F8260EEC-BE54-4669-AC59-E9ED12501C72Q34707429-FC3AA57B-C56D-4A3E-A9E2-656A2713C44EQ36204615-424E2A43-8335-48A3-BE87-BC906F86D8B8Q36284173-19E03B8E-17C4-49E1-92A7-8AD61B0C2914Q38254734-8A9BFF62-A61B-44F8-B449-015BFE198CB2Q38364794-401C5ED7-6735-4D61-BA92-9869DB300245Q38940104-BC216A34-F097-4F0F-A654-115C1E53A752Q46188046-A83E11C6-4649-4D35-A59D-E0D2797E3F9DQ50267579-259AA8D1-3780-45D8-A630-4716DDB11558Q52325699-5602081B-98DC-4CA7-8B37-A9D1EB12F7F3Q52629086-E2590AFF-8FF9-4ADC-9C34-17EABA51DF85Q56639210-1DFA97C2-1F32-4983-913D-7DF45C46BF39Q56966465-66F38350-5BE3-4678-9E1D-EEB3C0FD8E4A
P2860
The impact of single versus mixed schistosome species infections on liver, spleen and bladder morbidity within Malian children pre- and post-praziquantel treatment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
The impact of single versus mi ...... d post-praziquantel treatment.
@ast
The impact of single versus mi ...... d post-praziquantel treatment.
@en
type
label
The impact of single versus mi ...... d post-praziquantel treatment.
@ast
The impact of single versus mi ...... d post-praziquantel treatment.
@en
prefLabel
The impact of single versus mi ...... d post-praziquantel treatment.
@ast
The impact of single versus mi ...... d post-praziquantel treatment.
@en
P2093
P2860
P50
P356
P1476
The impact of single versus mi ...... d post-praziquantel treatment.
@en
P2093
Adama D Keita
Albis F Gabrielli
Aly Landouré
Elisa Bosqué-Oliva
Joanne P Webster
Mamadou Traoré
Moussa Sacko
Robert Dembelé
P2860
P2888
P356
10.1186/1471-2334-10-227
P577
2010-07-29T00:00:00Z
P5875
P6179
1004480416